CAPS1 regulates catecholamine loading of large dense-core vesicles by Speidel, Dina et al.
Neuron, Vol. 46, 75–88, April 7, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.neuron.2005.02.019
CAPS1 Regulates Catecholamine Loading
of Large Dense-Core VesiclesDina Speidel,1,7 Cathrin E. Bruederle,2,7
Carsten Enk,1 Thomas Voets,3,8
Frederique Varoqueaux,1 Kerstin Reim,1
Ute Becherer,2 Francesco Fornai,4,5
Stefano Ruggieri,5 Yvonne Holighaus,6
Eberhard Weihe,6 Dieter Bruns,2 Nils Brose,1,*
and Jens Rettig2,*
1Max-Planck-Institut fu¨r Experimentelle Medizin
Abteilung Molekulare Neurobiologie
D-37075 Göttingen
Germany
2Universität des Saarlandes
Physiologisches Institut
D-66421 Homburg/Saar
Germany
3Max-Planck-Institut fu¨r Biophysikalische Chemie
Abteilung Membranbiophysik
D-37077 Göttingen
Germany
4University of Pisa
Department of Human Morphology
and Applied Biology
I-56126 Pisa
Italy
5Laboratory of Neurobiology of Movement Disorders
IRCCS Neuromed
I-86077 Pozzilli (Isernia)
Italy
6Philipps-Universität Marburg
Institut fu¨r Anatomie und Zellbiologie
Abteilung Molekulare Neurowissenschaften
D-35033 Marburg
Germany
Summary
CAPS1 is thought to play an essential role in medi-
ating exocytosis from large dense-core vesicles
(LDCVs). We generated CAPS1-deficient (KO) mice
and studied exocytosis in a model system for Ca2+-
dependent LDCV secretion, the adrenal chromaffin
cell. Adult heterozygous CAPS1 KO cells display a
gene dosage-dependent decrease of CAPS1 expres-
sion and a concomitant reduction in the number of
docked vesicles and secretion. Embryonic homozy-
gous CAPS1 KO cells show a strong reduction in the
frequency of amperometrically detectable release
events of transmitter-filled vesicles, while the total
number of fusing vesicles, as judged by capacitance
recordings or total internal reflection microscopy, re-
mains unchanged. We conclude that CAPS1 is re-*Correspondence: brose@em.mpg.de (N.B.); jrettig@uniklinik-
saarland.de (J.R.)
7 These authors contributed equally to this work.
8 Present address: Laboratorium voor Fysiologie, KU Leuven, Cam-
pus Gasthuisberg Onderwijs & Navorsing, B-3000 Leuven, Belgium.quired for an essential step in the uptake or storage
of catecholamines in LDCVs.
Introduction
Regulated secretion of neurotransmitters, hormones, or
peptides is mediated by the Ca2+-dependent fusion of
secretory vesicles with the plasma membrane. Different
types of secretory vesicles, small clear vesicles (SCVs)
and large dense-core vesicles (LDCVs), are responsible
for the secretion of classical neurotransmitters and
peptides/neuromodulators, respectively. SCVs and LDCVs
employ a very similar set of proteins for the regulation
and execution of their Ca2+-triggered fusion with the
plasma membrane. Reflecting these molecular similari-
ties, the final phases of SCV and LDCV exocytosis are
characterized by the same basic vesicle trafficking
steps. Vesicles are first tethered at the plasma mem-
brane and then primed to fusion competence. Only
primed vesicles, representing the “readily releasable
vesicle pool,” are able to fuse with the plasma mem-
brane in response to rises in the intracellular Ca2+ con-
centration (Burgoyne and Morgan, 2003; Jahn et al.,
2003; Rettig and Neher, 2002; Su¨dhof, 1995).
Despite the fact that SCVs and LDCVs use similar
proteins to control and execute membrane fusion, the
two vesicle types differ in their morphology, lumenal
and membrane protein complement, biogenesis, traf-
ficking and recycling pathways, and release kinetics.
Even at the level of common trafficking steps such as
vesicle priming, differences in kinetics and regulatory
mechanisms are apparent (Burgoyne and Morgan,
2003), but the molecular causes for these functional dif-
ferences are unknown. Only very few proteins have
been proposed to be specifically involved in the secre-
tion of only one type of vesicle. One such protein is
CAPS1, which is thought to be essential for LDCV but
not SCV exocytosis (Ann et al., 1997; Berwin et al.,
1998; Hay and Martin, 1992; Tandon et al., 1998; Walent
et al., 1992).
CAPS1 is a 145 kDa protein that was discovered as
an essential cytosolic factor in Ca2+-triggered nor-
adrenaline (NA) release from cracked PC12 cells, where
it is required for a secretory step that follows ATP-
dependent priming (Ann et al., 1997; Hay and Martin,
1992; Walent et al., 1992). It contains a central PH do-
main whose binding to acidic phospholipids is essen-
tial for CAPS1 function, an MH domain, which is also
found in members of the Munc13 family of vesicle prim-
ing proteins, a C-terminal membrane association do-
main that mediates LDCV binding, and a core C2 do-
main (Grishanin et al., 2002). Recently, a second CAPS
isoform, CAPS2, was identified in mammals. CAPS2 is
structurally and functionally similar to CAPS1 but ex-
hibits a different cell/tissue and developmental expres-
sion pattern (Cisternas et al., 2003; Speidel et al., 2003).
While CAPS1 expression is specific for neuronal and
neuroendocrine tissues and the pancreas, CAPS2 is
also found in other tissues (Speidel et al., 2003). Anti-
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76body inhibition studies in chromaffin cells (Elhamdani n
Ket al., 1999) and melanotrophs (Rupnik et al., 2000) indi-
cated that CAPS1 is required for a late release phase of A
VLDCV exocytosis, possibly by modulating fusion pore
formation and dilation. Genetic studies on the inverte- m
wbrate orthologs in C. elegans (Avery et al., 1993) and
Drosophila (Renden et al., 2001) demonstrated that q
fCAPS is an essential protein with an important role in
the secretion of a subset of neurotransmitters. In Dro- c
nsophila, deletion of CAPS causes a 50% decrease in
glutamatergic transmission at neuromuscular junc- d
ztions. However, this may be an indirect effect, as ex-
pression of CAPS in motor neurons does not rescue a
(the phenotypic changes in neuromuscular junctions of
CAPS mutants (Renden et al., 2001). Currently, CAPS1 n
ris thought to act during the Ca2+-triggering step of reg-
ulated LDCV exocytosis and/or fusion pore opening i
and dilation, but the corresponding evidence is not un-
equivocal. Published functional data are almost exclu- m
Gsively based on antibody inhibition studies, and genetic
studies in C. elegans and Drosophila could not identify a
pthe LDCV trafficking step that is regulated by CAPS
proteins. m
tTo determine the function of CAPS1 in LDCV secre-
tion, we generated and analyzed CAPS1-deficient s
bmice (KOs).
(
eResults
c
Characteristics of CAPS1 KOs
A KO mutation in the murine CAPS1 gene was gener- S
Cated by homologous recombination in embryonic stem
cells and detected as described in the Experimental B
tProcedures (Figure 1A). Heterozygous CAPS1 KOs
were viable and fertile and showed no obvious pheno- t
ctypic alterations in the cage environment. Genotyping
of offspring resulting from interbreeding of heterozy- s
gous mutants (Figures 1A and 1B) showed that at birth
wild-type (wt; +/+), heterozygous KO (+/−), and homo- f
mzygous KO (−/−) pups were present at the expected
1:2:1 Mendelian frequency (41:81:41). Western blot o
hanalysis of mutant brains showed that CAPS1 expres-
sion was abolished in homozygous KOs and signifi- s
tcantly reduced to 44% ± 6% of wt levels in heterozy-
gous KOs (Figure 1C). The expression of representative p
pcontrol proteins (Secretogranin 2, Synaptotagmin 1,
Munc13-1, Munc18-1, and Syntaxin 1) was not altered t
u(Figure 1D).
Newborn homozygous CAPS1 KO pups breathed m
vslowly and moved only after tactile stimulation. After
birth, breathing rates decreased, and mutant mice died
rwithin 10–30 min. Despite this perinatally lethal pheno-
type, homozygous CAPS1 KO mice showed no obvious i
Fchanges of the body plan or individual organs (data not
shown). Structure and cytoarchitecture of the brain and o
oadrenal gland were indistinguishable from those seen
in wt littermates (Figure 1F). Likewise, lung and heart of z
homozygous newborn CAPS1 KOs as well as the brain
and adrenal gland of postnatal day 30 (P30) heterozy- f
wgous KOs were histologically normal (Figure 1F and
data not shown). m
fWestern blot analyses of vesicular proteins essential
for the filling of LDCVs with catecholamines in homoge- aates of adrenal glands from embryonic day 19 (E19)
O pups revealed expression levels of the vesicular H+-
TPase (111% ± 7%), of the monoamine transporters
MAT1 (87% ± 6%) and VMAT2 (w85%), and of Chro-
ogranin A (116% ± 9%) and CAPS2 (w104%) that
ere similar to wt levels (100%) (Figure 1E). Likewise,
uantification of protein levels in adrenal homogenates
rom P30 heterozygous CAPS1 KOs revealed no
hanges in expression levels of vesicular proteins (data
ot shown). In contrast, CAPS1 expression was re-
uced to about 65% ± 6% in adrenals of adult hetero-
ygous KO mice (Figure 1E). Immunohistochemical ex-
mination of VMAT1, VMAT2, and tyrosine hydroxylase
TH) in adrenal sections of E19 CAPS1 KO and wt adre-
als revealed no differences between genotypes with
espect to immunopositive cell numbers and staining
ntensity (Figure 1G).
Thus, CAPS1 is essential for postnatal survival of
ice but not for the regulation of their development.
iven the widespread expression of CAPS1 in neuronal
nd neuroendocrine tissues, possible reasons for the
erinatally lethal phenotype of CAPS1 KO mice are
anifold. We examined synaptic transmission in autap-
ic hippocampal neurons from CAPS1 KOs (data not
hown) as well as respiratory brainstem function in new-
orn CAPS1 KOs at the level of hypoglossal nerve activity
data not shown) and found no phenotypic changes. This
xcludes a general synaptic transmission deficit as the
ause of perinatal death of CAPS1 KOs.
ecretion from Heterozygous
APS1 KO Chromaffin Cells
ecause CAPS1 was discovered in PC12 cells and is
hought to act as an LDCV-specific regulator of secre-
ion, we analyzed LDCV secretion from KO adrenal
hromaffin cells, one of the best-characterized model
ystems of regulated secretion.
In chromaffin cells, secretory granules can reside in
our pools representing different functional states or
aturation steps. The size of these pools and the rate
f vesicle transition between them can be assayed with
igh-time resolution patch-clamp capacitance mea-
urements. Granules from the Depot pool translocate
o the plasma membrane to enter the docked but un-
rimed granule pool, UPP. Granules in the UPP are
rimed into the slowly releasable pool, SRP, from where
hey can enter the rapidly releasable pool, RRP. Gran-
les in the SRP and RRP can fuse with the plasma
embrane, but with different rate constants (w3–6 s−1
ersus w20–50 s−1) (Ashery et al., 2000).
Deletion of one CAPS1 allele in heterozygous KOs
esulted in a significant reduction of CAPS1 expression
n the adrenal gland of P30 animals (Figure 1E; see also
igure 1C for corresponding data from brain). Because
f this gene dosage effect, we performed electrophysi-
logical recordings on adrenal slices from P30 hetero-
ygous CAPS1 KOs and wt littermates.
Increases in membrane capacitance (Cm) resulting
rom Ca2+-dependent exocytosis were monitored using
hole-cell patch-clamp recordings on single chro-
affin cells stimulated either by depolarization or by
lash photolysis of caged Ca2+. Stimulation with a volt-
ge protocol consisting of six 10 ms depolarizations
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77Figure 1. Generation, Protein Expression,
and Morphology of CAPS1 KO Mice
(A) Deletion of murine CAPS1 gene. Maps of
the wild-type (wt) CAPS1 gene, the targeting
vector, and the resulting mutant gene are
shown. Positions of exons (black boxes with
bp of corresponding cDNA) and restriction
enzyme sites are indicated. The gray box in-
dicates the position of a probe used to iden-
tify the mutant allele. Neo, neomycin resis-
tance gene; HSV-TK, thymidine kinase gene.
(B) Southern blot and PCR analyses. Mouse
tail DNA from E19 wt mice (+/+) and mice
heterozygous (+/−) or homozygous (−/−) for
the mutation in the CAPS1 gene were ana-
lyzed. Positions of bands representing wt
and mutant (KO) alleles are indicated.
(C) CAPS1 expression in CAPS1 KO mice.
Brain homogenates (20 g protein per lane)
from E19 mice were analyzed by Western
blotting using anti-CAPS1 antibodies. Geno-
types as in (B).
(D) Expression of presynaptic proteins in
brain samples of CAPS1 KO mice. Brain ho-
mogenates (20 g protein per lane) from E19
mice were analyzed by Western blotting
using antibodies against the indicated pro-
teins. Genotypes as in (B). Sg II, Secreto-
granin 2; Syt I, Synaptotagmin 1; Stx 1, Syn-
taxin 1; Chr A, Chromogranin A.
(E) Expression of vesicular proteins in adre-
nal glands of CAPS1 KO mice. Adrenal ho-
mogenates (25 g protein per lane) were an-
alyzed by Western blotting using antibodies
against the indicated proteins. Vo ATPase, Vo
subunit of vesicular H+-ATPase; Chr A, Chro-
mogranin A; VMAT, vesicular monoamine
transporter.
(F) Morphology of brain and adrenals of
CAPS1 KO mice. Tissues of E19 and P30
mice were sectioned and processed for cre-
syl violet staining. Genotypes as in (B). White
scale bar, 2 mm; black scale bar, 200 m.
(G) Distribution of VMATs and tyrosine hy-
droxylase (TH) expression in adrenals from
CAPS1 KO mice. Adrenal glands of E19 mice
were sectioned and processed for immuno-
histochemistry using antibodies against
VMAT1, VMAT2, and TH. Genotypes as in (B).
VMAT, vesicular monoamine transporter; TH,
tyrosine hydroxylase. Scale bar, 50 m.followed by four 100 ms depolarizations delivered 300
ms apart (Figure 2A, top) induced voltage-gated Ca2+
influx and robust Cm increases in wt cells. The 10 ms
depolarizations cause the fusion of the immediately re-
leasable pool, IRP, which corresponds to a fraction of
the readily releasable granules in the RRP that are
closely associated with Ca2+ channels. The subsequent
100 ms depolarizations elicit the fusion of the remain-
der of the RRP (Voets et al., 1999). The depolarization-
evoked Cm increases in heterozygous KO cells were
only about 70% of those in wt control cells (Figure 2A,
bottom). Statistical analysis showed that both the IRPand RRP were significantly reduced in heterozygous
CAPS1 KO cells, although the amplitude of voltage-
gated Ca2+ currents remained unchanged (Figures 2B–
2D; Table S1 in the Supplemental Data available with
this article online). To investigate possible changes in
the Ca2+-dependent kinetics of exocytosis or in granule
recruitment, we stimulated wt and heterozygous CAPS1
KO cells using flash photolysis of the photolabile Ca2+
cage NP-EGTA. This resulted in stepwise, uniform in-
creases in [Ca2+]i to 20–30 M (Figure 2E, top). Again,
strikingly different secretory responses were obtained
for wt and heterozygous CAPS1 KO cells (Figure 2E,
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Figure 2. LDCV Secretion in Slices from E19 Homozygous and P30
Heterozygous CAPS1 KO Chromaffin Cells S
(A) Voltage protocol (top) and resulting average capacitance in- Ccrease (Cm) in P30 chromaffin cells from wt (n = 19 cells, four
Wanimals) and heterozygous CAPS1 KO (n = 24 cells, four animals)
amice. (B) IRP, determined as the average Cm during the time
period indicated by the leftmost dashed rectangle in (A). (C) RRP, C
determined as the average Cm during the time period indicated d
by the rightmost dashed rectangle in (A). (D) Peak Ca2+ current t
amplitude. (E) Averaged high-time resolution recordings of mem-
fbrane capacitance in response to flash photolysis of Ca2+ bound
KNP-EGTA from wt (black; n = 18 cells, four animals) and heterozy-
mgous CAPS1 KO (red; n = 21 cells, four animals) chromaffin cells.
The average intracellular Ca2+ concentration following the flash is c
shown in the upper trace. (F–H) Analysis of the two burst compo- K
nents, RRP and SRP, revealed a similar reduction in amplitude for t
both pools, while the rate of sustained release was unchanged. (I)
bVoltage protocol (top) and resulting average capacitance increase
C(Cm) in E19 chromaffin cells from wt (n = 13 cells, two animals)
band homozygous CAPS1 KO (n = 28 cells, three animals) mice. (J)
IRP, determined as the average Cm during the time period indi- u
cated by the leftmost dashed rectangle in (I). (K) RRP, determined t
as the average Cm during the time period indicated by the right- s
most dashed rectangle in (I). (L) Peak Ca2+ current amplitude. (M)
2Averaged high-time resolution recordings of membrane capaci-
stance in response to flash photolysis of Ca2+ bound NP-EGTA from
swt (black; n = 16 cells, two animals) and homozygous CAPS1 KO
(red; n = 25 cells, three animals) E19 chromaffin cells. The average c
intracellular Ca2+ concentration following the flash is shown in the n
upper trace. (N–P) Kinetic analysis of the capacitance traces re- K
vealed that the two burst components, RRP and SRP, and the rate
kof sustained release are unchanged. Error bars indicate standard
error of the mean.
E
Aottom). For both genotypes, the Cm increase con-
isted of a fast initial phase, the exocytotic burst, fol-
owed by a slower sustained phase of secretion. The
xocytotic burst represents exocytosis of all fusion-
ompetent granules, and the sustained component is
ue to recruitment and subsequent fusion of new gran-
les. The exocytotic burst of individual flash responses
an be fitted by the sum of two exponential terms, with
he fast and slower component corresponding to the
xocytosis of granules from two distinct populations of
usion-competent vesicles, the SRP and RRP (Ashery
t al., 2000; Voets et al., 1999). As predicted on the ba-
is of the depolarization experiments (Figure 2A), SRP
nd RRP were significantly reduced to a similar degree
n heterozygous CAPS1 KO cells as compared to wt
ontrols (w70% of wt levels; p < 0.02), while sustained
elease was unchanged (Figures 2F–2H; Table S1). The
ime constants for fusion of granules from the SRP and
RP were not different between wt and heterozygous
APS1 KO cells (data not shown), indicating that the
inetics of Ca2+-triggered fusion are not altered in the
artial absence of CAPS1.
These data show that reduction of CAPS1 expression
y 35% leads to a concomitant and comparable 30%–
5% reduction in releasable granule pools. This pool
eduction could be explained if CAPS1 acted as a rate-
imiting LDCV priming factor (Hay and Martin, 1992), or
f CAPS1 functioned upstream of the priming reaction,
.e., in the biogenesis, stability, trafficking, or docking of
DCVs. Deficits in the latter processes would ultimately
ead to a decrease in releasable granule pools.
ecretion from Homozygous
APS1 KO Chromaffin Cells
e next performed electrophysiological recordings in
drenal slices from littermate wt and homozygous
APS1 KO E19 embryos. Astonishingly, using the same
epolarization and flash photolysis protocols applied
o heterozygous chromaffin cells (Figures 2A–2H), we
ound no changes in secretion between homozygous
O and wt control cells as determined by capacitance
easurements. Statistical analysis revealed no signifi-
ant differences between wt and homozygous CAPS1
O cells in either the size of IRP and RRP or the ampli-
ude of voltage-gated Ca2+ currents (Figures 2I–2L; Ta-
le S1). When we stimulated wt and homozygous
APS1 KO cells using flash photolysis of the photola-
ile Ca2+ cage NP-EGTA, which resulted in stepwise,
niform increases in [Ca2+]i to 20–40 M (Figure 2M,
op), we again measured very similar secretory re-
ponses in wt and homozygous CAPS1 KO cells (Figure
M, bottom). Very similar values were obtained for the
ize of the SRP and RRP and for the rate of sustained
ecretion (Figures 2N–2P; Table S1). Moreover, the time
onstants for fusion of the SRP and RRP were not sig-
ificantly different between wt and homozygous CAPS1
O cells (data not shown), indicating that vesicle fusion
inetics are not altered in the absence of CAPS1 on E19.
xpression of CAPS Isoforms in Murine
drenal Gland
Two possible mechanisms may account for the finding
that chromaffin granule secretion from P30 heterozy-
CAPS1 Controls LDCV Loading
79Figure 3. Expression Levels of CAPS1 and
CAPS2 Isoforms in Adrenal Glands during
Development
Expression of CAPS1 and CAPS2 proteins in
mouse adrenal and brain. (A) Homogenates
from brains and adrenals (18 g protein per
lane) from P30 and E19 mice were analyzed
by SDS-PAGE and immunoblotting using an-
tibodies against CAPS1 and CAPS2. Asterisk
indicates an unspecific band detected by
CAPS2 antibodies. (B) Confocal images
through an embryonic (E19) chromaffin cell
immunolabeled with anti-CAPS1 (green, left)
and anti-CAPS2 (red, middle) antibodies.
Overlay of both channels (right) revealed al-
most no colocalization between both iso-
forms. Note that different antibodies than in
(A) were used (see Experimental Proce-
dures). Scale bar, 5 m.gous CAPS1 KO chromaffin cells—where CAPS1 ex-
pression is at about 60%–70% of wt levels—is reduced
by about 30%, while E19 homozygous KO cells lacking
CAPS1 are not affected (Figure 2). Either embryonic
chromaffin cells utilize a vesicle maturation pathway
that does not depend on CAPS proteins (e.g., involving
Munc13 isoforms), or CAPS2 compensates for the
CAPS1 loss in embryonic but not in adult cells.
CAPS1 and CAPS2 expression levels in brain are dif-
ferentially regulated during development (Speidel et al.,
2003). CAPS1 protein expression is similar to that of
synaptic markers. It is first detectable late in embryo-
genesis (E14) and increases to reach a plateau 20 days
after birth, when most synapses have been formed. In
contrast, CAPS2 protein expression levels are more
stable during development and even higher in the em-
bryonic brain than in later phases of development. To
test whether CAPS1 and CAPS2 expression in the adre-
nal gland is also differentially regulated during develop-
ment, we examined corresponding mRNA and protein
levels by in situ hybridization, immunocytochemistry,
and Western blot analysis of brains and adrenal glands
from P30 and E19 mice.
In situ hybridization experiments with isoform-spe-
cific radiolabeled antisense oligonucleotides (Speidel
et al., 2003) showed that CAPS1 mRNA is abundantly
and specifically expressed in cells of the P30 mouse
adrenal medulla. CAPS1 mRNA levels in E19 and P30
mouse chromaffin cells were similar (Figure S1A). No
CAPS1 mRNA was detectable in adrenal sections ob-
tained from homozygous CAPS1 KOs (data not shown).
In contrast, when CAPS2-specific antisense oligonucle-
otides were used, corresponding mRNA levels were
found to be high only in E19 mouse chromaffin cells,
but at or below the detection limit in adult mouse adre-
nal gland (Figure S1A).
Immunocytochemical experiments showed that the
differential developmental regulation of CAPS1 and
CAPS2 mRNA expression levels is reflected by the cor-
responding protein expression levels. Using CAPS1
and CAPS2 isoform-specific antibodies, we immunode-
tected CAPS1 and CAPS2 in chromaffin cells of the E19
mouse adrenal gland medulla. However, in chromaffincells of P30 mouse adrenal glands, only CAPS1 but not
CAPS2 was detectable (Figure S1B). Western blot
analyses of brain and adrenal homogenates from E19
and P30 mice showed that CAPS1 expression is stable
or upregulated during development, while CAPS2 ex-
pression is downregulated (Figure 3A). This effect was
most striking in the adrenal, where CAPS1 is barely de-
tectable at E19 and robustly expressed in P30 animals,
while CAPS2 is present only in E19 tissue but absent
at P30 (Figure 3A). After determining the titers of our
anti-CAPS antibodies (see Experimental Procedures),
we estimated the relative amounts of CAPS1 and
CAPS2 in the different tissues at different develop-
mental stages by densitometric analyses of Western
blots. CAPS1 protein levels in the adult adrenal gland
were at least two times higher than corresponding
CAPS2 levels. In contrast, CAPS2 protein levels in adre-
nals from E19 mice were about eight times higher than
corresponding CAPS1 levels (Figure 3A). The situation
in brain tissue is similar but less pronounced, and both
full-length CAPS2 and a smaller splice variant of CAPS2,
most likely lacking a 333 bp exon (Speidel et al., 2003),
are expressed in adult mouse brain (Figure 3A).
To investigate the subcellular localization of CAPS1
and CAPS2, we performed immunocytochemical analy-
ses on isolated chromaffin cells from E19 adrenal
glands. Most CAPS1 and CAPS2 immunoreactivity was
localized to small punctate structures (Figure 3B). Inter-
estingly, very little overlap between CAPS1 and CAPS2
immunoreactive structures was observed (Figure 3B),
indicating that the two CAPS isoforms may reside on
different populations of LDCVs.
Thus, CAPS1 and CAPS2 levels are inversely corre-
lated, and the two isoforms are most likely targeted to
different subpopulations of LDCVs in mouse chromaffin
cells, and the fact that loss of one CAPS1 allele leads
to reduced secretory activity in P30 chromaffin cells, as
determined by Cm measurements, while complete loss
of CAPS1 expression in E19 mice has no effect (Figure
2), can in part be explained by redundant expression of
CAPS2 only in embryonic but not in adult adrenal
tissue.
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aHeterozygous CAPS1 KO Chromaffin Cells
We next performed amperometric measurements, which
detect the catecholamines released from chromaffin S
granules by oxidation on the surface of a carbon fiber H
electrode (Bruns and Jahn, 1995). W
Typically, the ratio between quantal monoamine con- l
tent and vesicle volume is rather constant (Bruns et al., m
2000). The observed reduction in secretion from P30 w
heterozygous CAPS1 KO mice (Figure 2) could be due g
either to a reduced number of vesicles residing in RRP S
and SRP or to a reduced size of individual vesicles. To r
distinguish between these possibilities, we stimulated C
isolated chromaffin cells with 80 mM KCl for 20 s and 0
measured the resulting amperometric spikes during the e
KCl application with a 5 m carbon fiber electrode. The 0
spike frequency in heterozygous CAPS1 KO cells was g
reduced to w65% of wt levels (1.18 ± 0.11 events/s [n = c
21] in control cells and 0.75 ± 0.09 events/s [n = 21] in
heterozygous CAPS1 KO cells; p % 0.003; Figures 4A r
and 4G; Table S2). This reduction is in agreement with f
the observed reduction in CAPS1 expression levels o
(Figures 1C and 1E) and secretion measured in capaci- a
tance recordings (Figure 2). No difference in charge, s
amplitude, 50%–90% rise time, half-width, and foot du- t
ration of spikes was observed (Figures 4B–4F). s
Thus, the reduction in secretion from chromaffin cells a
of P30 heterozygous CAPS1 KO mice observed in ca- c
pacitance measurements following depolarization orFigure 4. Frequency of Amperometric Events in P30 Heterozygous CAPS1 KO Mice
(A) Representative traces of carbon fiber amperometry measurements from isolated chromaffin cells of P30 wt and heterozygous CAPS1 KO
mice. Secretion was triggered by extracellular application of 80 mM K+ as indicated (gray bar).
(B–G) Frequency distribution of individual single spike parameters obtained from the analysis of 21 wt and 21 heterozygous CAPS1 KO cells.
Charge (B), amplitude (C), 50%–90% rise time (D), half-width (E), and foot duration (F) were indistinguishable between both groups, while the
frequency of amperometric events in heterozygous CAPS1 KO cells was significantly reduced by approximately 35% compared to wt cells
([G]; p < 0.003). Error bars indicate standard error of the mean.flash photolysis (Figure 2) can be attributed to a reduc-ion in the number of releasable vesicles in the RRP
nd SRP.
ingle Secretory Granule Fusion Events in E19
omozygous CAPS1 KO Chromaffin Cells
e next performed amperometric recordings on iso-
ated E19 chromaffin cells of homozygous CAPS1 KO
ice. Based on our capacitance recordings (Figure 2),
e expected to see no difference in frequency and sin-
le spike parameters between wt and CAPS1 KO cells.
urprisingly, measurements from four different animals
evealed that the frequency of amperometric spikes in
APS1 KO cells was only w40% of wt levels (1.85 ±
.13 events/s [n = 27] in control cells and 0.73 ± 0.22
vents/s [n = 26] in homozygous CAPS1 KO cells; p %
.0001; Figures 5A and 5G; Table S2). Like in heterozy-
ous animals, the single spike characteristics were un-
hanged (Figures 5B–5F; Table S2).
To test the specificity of this finding, we performed
escue experiments by overexpressing a CAPS1-GFP
usion protein in E19 CAPS1 KO cells. Reintroduction
f CAPS1-GFP into CAPS1 KO chromaffin cells led to
complete recovery of the frequency of amperometric
pikes (2.05 ± 0.52 events/s [n = 9]; Figure 5G), while
he introduction of GFP alone had no effect (data not
hown). Thus, the reduction of spike frequency medi-
ted by the selective loss of CAPS1 expression is spe-
ific and reversible.
The discrepancy between capacitance and ampero-metry recordings in E19 homozygous CAPS1 KO mice
CAPS1 Controls LDCV Loading
81Figure 5. Frequency of Amperometric Events in E19 Homozygous CAPS1 KO Mice
(A) Representative traces of carbon fiber amperometry measurements from isolated chromaffin cells of E19 wt and homozygous CAPS1 KO
mice. Secretion was triggered by extracellular application of 80 mM K+ as indicated (gray bar).
(B–G) Frequency distribution of individual single spike parameters obtained from the analysis of 21 wt and 21 homozygous CAPS1 KO cells.
Charge (B), amplitude (C), 50%–90% rise time (D), half-width (E), and foot duration (F) were indistinguishable between both groups, while the
frequency of amperometric events in homozygous CAPS1 KO cells was significantly reduced by approximately 60% compared to wt cells
([G]; p < 0.0001). Reintroduction of CAPS1 into CAPS1 KO cells led to a complete recovery of the frequency of amperometric events ([G];
p < 0.002). Error bars indicate standard error of the mean.(Figures 2 and 5) prompted us to perform simultaneous
capacitance and amperometry recordings following
flash photolysis of NP-EGTA. Measurements from 12
control and 12 CAPS1 KO cells confirmed that the ca-
pacitance response was identical and the amperomet-
ric response was reduced in CAPS1 KO cells as com-
pared to wt control cells (Figure S2).
Two alternative scenarios might account for this phe-
nomenon. First, CAPS1 might have a role in both exo-
and endocytosis. The absence of CAPS1 would lead to
the fusion of fewer vesicles, as evidenced by the lower
spike frequency (Figures 5A and 5G), but concomitantly
to a decrease of endocytosis by exactly the same mag-
nitude. In view of our knowledge about CAPS function,
this possibility is highly unlikely. Second, CAPS1 might
be involved in the filling of vesicles with catechola-
mines. The absence of CAPS1 would lead to the gener-
ation of empty vesicles, which in the embryonic state
would still be correctly docked and primed at the
plasma membrane. Fusion of these vesicles upon stim-
ulation would then lead to an increase in capacitance
of the plasma membrane but would not be detected in
amperometric recordings. The existence of such empty
vesicles in chromaffin cells has been demonstrated
previously (Gong et al., 2003; Tabares et al., 2001).
To support our electrophysiological findings on E19
CAPS1 KO chromaffin cells with an independent tech-
nique, we performed total internal reflection fluores-
cence microscopy (TIRFM) on E19 CAPS1 KO cells andtheir wt counterparts. The TIRFM technology allows to
visualize single vesicles arriving at the plasma mem-
brane, where they lose their mobility following docking
and priming. Additionally, the fusion of vesicles following
depolarization can be investigated reliably (Becherer et
al., 2003; Steyer et al., 1997).
To specifically label LDCVs, we infected isolated
chromaffin cells from E19 wt and CAPS1 KO mice with
a virus expressing Neuropeptide Y (NPY) fused to
Venus, a yellow variant of GFP. After a resting period of
30 s, during which we counted the number of labeled
vesicles at the plasma membrane (Figures 6A and 6B),
secretion was triggered by extracellular application of
80 mM K+ for 20 s. During this application, a fraction of
membrane-associated vesicles fused with the plasma
membrane as detected by a sudden loss of fluores-
cence in TIRFM. Simultaneously, we measured cate-
cholamine secretion by amperometry (Figures 6A and
6B). Quantitative analysis of the data from 16 wt (two
animals) and 16 CAPS1 KO cells (two animals) revealed
that the number of fused vesicles measured by TIRFM
was identical between the two groups. In contrast, the
number of fusion events measured in amperometry was
again significantly lower (w30% of wt levels; p <
0.0001) in CAPS1 KO cells (Figure 6B). Plotting the fu-
sion events in amperometry against the fusion events
in TIRFM revealed a linear correlation for wt cells but
no correlation for CAPS1 KO cells (Figure 6C).The combined TIRFM/amperometry measurements
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Measured by Simultaneous Amperometry
and TIRFM
(A) Example of a homozygous CAPS1 KO
E19 cell measured simultaneously with
TIRFM and carbon fiber amperometry. Vesi-
cles were labeled by overexpression of a
NPY-Venus construct, and secretion was
triggered by application of 80 mM K+ as indi-
cated in the stimulus protocol (upper panel).
TIRFM images of NPY-Venus-labeled vesi-
cles before (left) and after (right) stimulation
are shown in the middle panel. Vesicles that
fused during stimulation are marked with ar-
rows in the left image. The corresponding
trace of the amperometric measurement
during stimulation is shown in the lower
panel.
(B) Quantitative comparison of averaged wt
(n = 16 cells, two animals; white bars) and
CAPS1 KO (n = 16 cells, two animals; gray
bars) cells measured simultaneously with
TIRFM and amperometry. The left pair of col-
umns shows the number of vesicles marked
with NPY-Venus at the beginning of the ex-
periment. No significant difference in vesicle
number could be observed between the two
populations. During stimulation, the number
of secreted vesicles as visualized by TIRFM
was also not significantly changed (middle
pair of columns). The right pair of columns
shows the number of amperometric events
recorded simultaneously during high-K+ application. The number of events in CAPS1 KO cells was significantly reduced to approximately
30% of wt levels (p < 0.0001). Error bars indicate standard error of the mean.
(C) Plot of exocytotic events measured by TIRFM versus exocytotic events measured simultaneously by amperometry. As expected, there is
a linear correlation between both secretion assays in wt cells (black circles), but no correlation in CAPS1 KO cells (gray squares).are in excellent agreement with the data obtained from f
esingle capacitance, single amperometry, and combined
capacitance/amperometry measurements. The data in- K
wdicate that the absence of CAPS1 in chromaffin cells
leads to a defect in the biogenesis, stability, catechola- m
±mine filling, or catecholamine storage of a subset of
LDCVs, while the capability of LDCVs to fuse with the m
tplasma membrane in a Ca2+-dependent manner re-
mains unaffected.
e
nUltrastructure of Homozygous and Heterozygous
gCAPS1 KO Chromaffin Cells
cWe next analyzed the ultrastructure of mutant chro-
bmaffin cells to examine possible deficits in secretory
granule biogenesis or granule docking at the plasma
membrane, which should be detectable as a reduction D
Lin the overall number of granules and in the number of
docked vesicles, respectively. T
eUltrathin sections from P30 and E19 adrenals were
analyzed electron microscopically (Figures 7A and 7B). f
dSigns for a degeneration of vesicles or of other cellular
organelles, or signs of apoptosis, were not detectable a
win either P30 heterozygous or E19 KO chromaffin cells,
and no accumulation of vesicular structures lacking the g
wtypical dense core was detected in E19 chromaffin
cells. To investigate whether LDCV numbers in CAPS1 (
Dmutants at one of the studied developmental stages are
changed, we examined the number and distribution of c
oLDCVs in wt and CAPS1 mutant cells. In E19 homozy-
gous KO chromaffin cells (n = 19 cells, two animals), l
vesicle numbers and distribution were indistinguishablerom wt values (n = 21, two animals; Figure 7D). How-
ver, in P30 chromaffin cells from heterozygous CAPS1
O cells, we found a reduction in the number of LDCVs
ithin a distance of up to 200 nm from the plasma
embrane (i.e., morphologically docked vesicles; 71%
6% of wt; p < 0.026; Figure 7C). Numbers of LDCVs
ore distant from the plasma membrane were not al-
ered (Figure 7C).
Thus, the observed reduction in secretion in P30 het-
rozygous CAPS1 KO cells is due to a reduction in the
umber of membrane-proximal LDCVs. For homozy-
ous E19 KO cells, the normal number of LDCVs ex-
ludes an effect of CAPS1 loss on secretory granule
iogenesis or granule docking.
etermination of Catecholamine and Catechol
evels in Intact Adrenals
o investigate whether the reduced frequency of amp-
rometric signals in CAPS1 KO chromaffin cells is re-
lected by a reduction of total catecholamine levels, we
etermined the monoamine content in homogenates of
drenal glands by HPLC. Only dopamine (DA) levels
ere significantly decreased in adrenals from homozy-
ous KO mice (n = 12 animals) to about 71% ± 4% of
t levels (n = 12 animals; p < 0.02), whereas adrenaline
ADR) and NA levels were not altered (Figure 8A). As
A usually represents only a minor fraction of the total
atecholamine pool in chromaffin cells (2%–10%), the
bserved overall change in KO cells was surprisingly
ow given the robust difference in our amperometric re-
cords.
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83Figure 7. Ultrastructure of Chromaffin Cells from Heterozygous and Homozygous CAPS1 KO Mice
(A and B) Representative electron micrographs of chromaffin cells from P30 (A) and E19 (B) CAPS1 wt (+/+), heterozygous (+/−), and homozy-
gous (−/−) KO mice. Scale bars, 1 m and 200 nm (inset). (C) Quantitative analysis of LDCVs of 21 wt and 19 heterozygous CAPS1 KO
chromaffin cells from P30 mice (two animals for each genotype). The fraction of “morphologically docked” vesicles (<200 nm from the plasma
membrane) is reduced in CAPS1 heterozygous animals. *p < 0.05. (D) Quantitative analysis of LDCVs of chromaffin cells from E19 wt (n = 16
cells, two animals) and CAPS1 KO (n = 16 cells, two animals) mice. The overall number and distribution of vesicles is similar. Error bars
indicate standard error of the mean.Inhibition of catecholamine uptake into chromaffin
granules by reserpine causes a massive increase of cy-
tosolic catechols, which results from the rapid degra-
dation of catecholamines accumulating in the cytosol
(Mosharov et al., 2003). As all our physiological data
indicated a defect in catecholamine uptake and/or stor-
age in CAPS1 KO chromaffin granules (Figures 5 and
6), we expected a similar catechol accumulation in
CAPS1 KO chromaffin cells. Indeed, we found the
levels of the NA/ADR metabolite 3,4-dihyroxyphe-
nylethyleneglycol (DOPEG) in CAPS1 KO adrenals to be
strongly increased to 345% ± 60% of wt levels (twelve
animals; p < 0.0012). In contrast, the levels of the DA
metabolite 3,4-dihydroxyphenylacetic acid (DOPAC),
which in wt adrenals are ten times lower than DOPEG
levels, and of the DOPEG methylation product 3-meth-
oxy-4-hyroxyphenylethyleneglycol (MOPEG), which are
usually similar to the DOPEG levels under wt condi-
tions, were only slightly increased over the correspond-
ing wt levels (Figure 8B).
As an alternative approach to estimate total mono-
amine content, we treated adrenal gland sections from
E19 wt and CAPS1 KO cells with glyoxylic acid, which
reacts with monoamines, leading to fluorescence sig-
nals. Fluorescence intensity was diffuse and lower inchromaffin cells from homozygous CAPS1 KOs as com-
pared to control tissue (Figure 8C). As catecholamines
are 10,000 times more concentrated in vesicles than in
the cytosol (Parsons, 2000), the largest fraction of the
respective fluorescence signals is most likely derived
from vesicular catecholamine pools, whereas cytosolic
catecholamine levels are probably at or below the de-
tection limit of this assay. This is reflected by the prefer-
entially punctate signals in control cells as compared
to the more diffuse fluorescence observed in CAPS1
KO cells (Figure 8C, insets).
These data show that, except for DA, overall cate-
cholamine levels are well maintained in CAPS1 KO
chromaffin cells. However, cytosolic catechol levels in
CAPS1 KO chromaffin cells are strongly increased, indi-
cating that a significant proportion of catecholamines is
shifted from vesicular to cytosolic pools and degraded.
Discussion
We show here that CAPS1, a regulator of LDCV secre-
tion, is essential for postnatal survival but not for em-
bryonic development. In physiological experiments, we
made the unexpected observation that, in the absence
of CAPS1, embryonic chromaffin cells release up to
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gFigure 8. Tissue Catecholamine Content in Adrenals from CAPS1
KO Mice l
G(A) HPLC analysis of total adrenal content of catecholamines. Adre-
nal homogenates of 12 CAPS1 wt (+/+), 21 CAPS1 (+/−), and 12 g
CAPS1 (−/−) E19 KO mice were used for HPLC assessment. Re- N
sults are presented as the mean ± SEM. Only DA levels are signifi- f
cantly decreased (71% ± 4%; p < 0.02) compared to wt (100%). NA
sand ADR levels are not significantly altered (p = 0.13 [NA] and p =
d0.37 [ADR]) in CAPS1 KO mice compared to wt mice.
c(B) HPLC analysis of total catechol content of adrenals. Adrenal
homogenates of 12 CAPS1 wt (+/+) and 12 CAPS1 (−/−) E19 KO c
mice were used for HPLC assessment. Results are presented as t
the mean ± SEM. DOPEG levels are significantly increased 2
(345% ± 60%; p < 0.0012) compared to wt (100%). DOPAC and m
MOPEG levels are only slightly increased over wt levels (p = 0.53
f[DOPAC] and p = 0.61 [MOPEG] in CAPS1 KO mice compared to
mwt mice).
g(C) Glyoxylic acid-induced catecholamine fluorescence in adrenal
glands from E19 wt and CAPS1 KO mice. Sections from unfixed i
adrenal glands were stained simultaneously, and pictures were 2
captured with a confocal laser scanning microscope using identical i
settings for KO and wt samples. Note the reduced fluorescence d
intensity in adrenal medulla from CAPS1 KO compared to wt mice.
cScale bars, 20 m and 5 m (enlarged images).
c
m
p
70% empty LDCVs lacking catecholamine content (Fig- w
ures 5 and 6). This phenotype is paralleled by a 25%– m
30% reduction in total adrenal DA levels (Figure 8A),
a 3.5-fold increase of the cytosolic metabolite DOPEG a
(Figure 8B), and a decrease in vesicular catecholamines c
as assessed by glyoxylic acid cytochemistry (Figure l
8C), but normal ultrastructure and LDCV density (Figure c
7D), and normal expression of transmitter carriers and n
selected transmitter biosynthetic enzymes (Figures 1E d
and 1G). In adult heterozygous chromaffin cells lacking t
one CAPS1 allele, only secretion of transmitter-filled e
LDCVs and no release of empty vesicles is observed, n
abut overall secretion is reduced by 30%–35% (Figuresand 4) due to an underlying decrease in the number
f membrane-proximal LDCVs (Figure 7C).
In homozygous CAPS1 KO chromaffin cells, we ob-
erved that up to 70% of all LDCV secretory events
hat are detectable by capacitance measurements and
IRFM can not be detected by amperometric recording
f released catecholamine (Figures 2, 5, and 6 and Fig-
re S2). The only plausible explanation for this finding
s that CAPS1 KO cells fuse LDCVs that do not contain
atecholamines. The phenomenon that chromaffin cells
ontain LDCVs that fuse with the plasma membrane
ithout containing catecholamines has been demon-
trated previously by patch amperometry (Gong et al.,
003; Tabares et al., 2001). These studies revealed that
%–8% of chromaffin granules are devoid of catechola-
ines, and this number increased to 47% of total fuso-
enic vesicles upon specific blockade of the vesicular
onoamine transporter VMAT with reserpine (Tabares
t al., 2001). In light of these data, our experimental
esults on CAPS1 KO cells indicate a role for CAPS1 in
atecholamine uptake or storage.
Monoamine uptake into chromaffin granules is medi-
ted by two transporters, VMAT1 and VMAT2, which are
riven by a H+ electrochemical gradient generated by
Vo H+ ATPase (Erickson et al., 1996; Parsons, 2000;
chuldiner, 1994). In chromaffin cells, NA synthesis de-
ends on the uptake of its precursor DA into chromaffin
ranules and its subsequent conversion by intragranu-
ar DA-β-hydroxylase (Markoglou and Wainer, 2001).
eneration of ADR occurs after leakage of NA from
ranules and conversion by phenylethanolamine-
-methyltransferase (Henry et al., 1998). Adult dif-
erentiated chromaffin cells store either ADR or NA in
ecretory granules, and cytosolic catecholamines are
egraded rapidly. In contrast, embryonic chromaffin
ells produce and store all catecholamine types, and
ytosolic concentrations are significant, possibly due
o less degradation (Iwasa et al., 1999; Mosharov et al.,
003; Peaston and Weinkove, 2004). In both develop-
ental stages, uptake and leakage of catecholamines
rom granules has to be tightly controlled in order to
aintain synthesis of ADR and to guarantee proper
ranule filling. However, the mechanism of leakage and
ts control are unknown (Parsons, 2000; Schonn et al.,
003). In neurons, blockade of catecholamine uptake
nto vesicles due to a VMAT2 KO mutation leads to a
ramatic decrease in the total brain levels of all cate-
holamines, while heterozygous KOs show only minor
hanges (Wang et al., 1997). In addition, inhibition of
onoamine uptake into chromaffin granules by reser-
ine causes a massive increase of cytosolic catechols,
hich results from the rapid degradation of catechola-
ines in the cytosol (Mosharov et al., 2003).
Our finding that DA levels in CAPS1 KO embryonic
drenals are reduced by 25%–30%, while ADR and NA
oncentrations are normal (Figure 8A), and that the
evels of the main NA/ADR metabolite DOPEG are in-
reased dramatically (Figure 8B) is compatible with the
otion that these KO chromaffin cells have a selective
eficit in granular catecholamine uptake or storage and
herefore contain and fuse a significant population of
mpty granules. In that respect, the CAPS1 KO sce-
ario with about 60%–70% empty vesicles (Figures 5
nd 6) is comparable to the heterozygous VMAT2 KO
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85situation, where in contrast to the homozygous KO, up-
take is still operational at reduced rates, and only slight
reductions in catecholamine levels are observed in
brain (Wang et al., 1997), or to conditions of reserpine-
mediated inhibition of monoamine uptake, where cate-
chols were shown to accumulate in the cytosol (Mo-
sharov et al., 2003). Under CAPS1 KO conditions, the
shuttling of catecholamines through a subpopulation of
vesicles would still be maintained and sufficient to gen-
erate normal amounts of NA and ADR, while uptake or
storage in a second subpopulation of granules is dis-
turbed, leading to less catecholamine accumulation
and breakdown of the cytosolic pools to catechol me-
tabolites. Why DA levels are affected so selectively re-
mains unclear but may be a feature of embryonic chro-
maffin cells. It is possible that newborn chromaffin cells
respond to the CAPS1 loss and the concomitant defect
in the uptake or storage of catecholamines in a com-
pensatory manner by increasing synthesis rates and
thereby roughly maintain cellular catecholamine levels.
The data obtained with glyoxylic acid cytochemistry
(Figure 8C) indicate that individual chromaffin cells
have reduced granular catecholamine levels. The in-
tense punctate glyoxylic acid staining seen in wt cells,
which most likely resembles catecholamines stored in
granula, is less apparent in CAPS1 KO cells. Together
with our data on total catecholamine and catechol
levels in adrenals, this indicates that catecholamines
are either not taken up or not stored in CAPS1 KO gran-
ules and therefore diluted into the cytosol and de-
graded.
Surprisingly, adult heterozygous CAPS1 KO chro-
maffin cells show no discrepancy between fusion and
transmitter release events (Figure 2), indicating an ab-
sence of empty granules lacking catecholamine. How-
ever, these cells exhibit concordant 25%–30% reduc-
tions in secretion and membrane-proximal granule
numbers, which is best explained by a selective loss
of granules. We postulate a quality control mechanism,
according to which, during maturation of the adrenal
gland, heterozygous CAPS1 KO chromaffin cells elimi-
nate the empty vesicle population that is initially gener-
ated due to the partial lack of CAPS1 and the segrega-
tion of CAPS2 to a different granule population (see
below).
While all our functional data point to a role of CAPS1
in chromaffin granule transmitter loading or storage,
the molecular basis of this effect is unclear. CAPS1
does not interfere with the expression or localization of
the proteins essential for uptake activity, i.e., VMATs
and the Vo ATPase, as protein levels of VMATs and sub-
units of the Vo ATPase are not altered in CAPS1 KO
chromaffin cells (Figures 1E and 1G), and VMAT distri-
bution to structures resembling secretory granules is
normal (data not shown). Nevertheless, CAPS1 could
directly affect the function of VMATs or the Vo ATPase
and thereby regulate catecholamine uptake or storage.
Such a regulatory effect has been described for certain
heterotrimeric G proteins (Ahnert-Hilger et al., 2003).
Gαo2, Gαq11, Gβ2, and Gβ5 subunits are present on
chromaffin granules of the rat adrenal medulla and co-
localized with either VMAT1 or VMAT2 (Pahner et al.,
2002). Low concentrations of Gαo2 inhibit catechola-
mine accumulation in chromaffin granules to about thesame extent as the general G protein activator
GMppNp, while GDPβS has no effect (Pahner et al.,
2002), indicating that active heterotrimeric G proteins
downregulate the catecholamine content of chromaffin
granules by inhibiting catecholamine uptake or storage.
Recent studies in C. elegans showed that loss-of-func-
tion mutations in the heterotrimeric Go protein sup-
pressed the phenotype of unc-31 (CAPS) mutants (E.
Jorgensen, personal communication). This indicates
that CAPS acts in the same pathway as heterotrimeric
G proteins, exerting its function either by inhibiting ve-
sicular G proteins or by activating, in antagonism to
G proteins, VMATs. Alternatively, CAPS may influence
granular membrane composition or stability and thereby
regulate catecholamine uptake or prevent leakage. The
fact that the level of the major ADR/NA metabolite
DOPEG is selectively increased while the levels of the
main DA metabolite DOPAC are only marginally altered
in CAPS1 KOs indicates that, in CAPS1 KO chromaffin
cells, DA is still taken up into granules and converted
to NA, but NA and ADR leak out of these granules, re-
sulting in their more rapid conversion to DOPEG.
At first glance, the mouse CAPS1 KO phenotype is
different from that observed in Drosophila, where a
50% decrease in glutamatergic transmission at neuro-
muscular junctions and a concomitant accumulation of
SVs and in particular LDCVs was observed (Renden et
al., 2001). The Drosophila phenotype was interpreted
as an indirect effect of an upstream dysregulation in
hormone signaling (Renden et al., 2001), but it is pos-
sible that an analysis of direct effects of CAPS loss,
e.g., on catecholamine release in mutant flies, will yield
data that are compatible with our findings. Whether the
functional consequences of CAPS1 action observed in
PC12 cells (Ann et al., 1997; Hay and Martin, 1992; Wa-
lent et al., 1992) are compatible with a role of CAPS in
catecholamine uptake or storage remains to be ex-
plored.
Despite the detailed biochemical characterization of
CAPS1 interactions with LDCVs, lipids, and plasma
membrane proteins or protein components of the fu-
sion machinery (Wassenberg and Martin, 2002), infor-
mation regarding the physiological function of CAPS
proteins, beyond the notion of a general role in con-
trolling LDCV secretion, is scarce. Elhamdani et al.
(1999) loaded affinity-purified anti-CAPS1 antibodies
into calf chromaffin cells and measured the kinetics of
catecholamine release by amperometry and capaci-
tance recordings. They observed a reduction in the fre-
quency of amperometric events by about 80%, which
is in agreement with our data (Figures 5 and 6). In addi-
tion, a dramatic effect of anti-CAPS1 antibodies on the
time course of secretion of individual vesicles was re-
ported (prolonged mean rise time and half-width of
amperometric peaks), and a role of CAPS1 in the final
stage of Ca2+-triggered secretion at the level of the fu-
sion step was concluded. We measured 614 and 305
individual fusion events in heterozygous and homozy-
gous CAPS1 KO chromaffin cells, respectively, but
found no evidence for an effect of CAPS1 loss on single
spike parameters (Figures 4 and 5; Table S2), ruling out
a role of CAPS1 in fusion or fusion pore expansion.
CAPS1 and CAPS2 are highly homologous and have
very similar activities in in vitro assays of LCDV secre-
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86ttion from PC12 cells (Speidel et al., 2003), but in vivo,
wCAPS1 and CAPS2 are developmentally and spatially
segregated in chromaffin cells (Speidel et al., 2003).
MThis leads to an almost perfect inverse correlation be-
C
tween CAPS1 and CAPS2 levels such that coexpres- o
sion occurs only in a rather brief time window (Figure p
s3A and Figure S1). Moreover, CAPS1 and CAPS2 ap-
ppear to be present on two different types of LDCVs in
dchromaffin cells (Figure 3B), indicating a complemen-
atary function and excluding the possibility that the
A
CAPS1 KO phenotype observed here is influenced by l
the redundant activity of CAPS2. o
VHow and why CAPS1 and CAPS2 are differentially
tregulated during development and spatially segregated
(into two different vesicle populations in chromaffin cells
wremains unknown. It is possible that they bind to and
a
sort vesicles with different cargo (e.g., ADR versus NA) w
or that they represent LDCVs of different biogenic a
forigin.
u
IExperimental Procedures
w
lIn this study, wt, heterozygous (+/−) CAPS1 KO, or homozygous
a(−/−) CAPS1 KO mice from E19 and P30 were used for all experi-
rments.
F
aStem Cell Experiments
aCAPS1 KO mice were generated by homologous recombination in
dembryonic stem cells as described (Augustin et al., 1999; Thomas
uand Capecchi, 1987). For the CAPS1 targeting vector (Figure 1A),
the genomic clone pBS-CAPS-8.2 containing two coding exons
Q(homologous to bp 1026–1258 and bp 1259–1380 of rat CAPS1
AcDNA; GenBank accession number U16802) was used. In the
atargeting vector, the 3# exon (bp 1259–1380) representing residues
q399–439 of CAPS1 protein was replaced by a neomycin resistance
gcassette. Following electroporation and selection, recombinant
istem cell clones were analyzed by Southern blotting after digestion
aof genomic DNA with XbaI. Four recombinant clones were iden-
ctified, one of which was injected into mouse blastocysts to obtain
highly chimeric mice that transmitted the mutation through the
germline. To verify germline transmission, Southern blots with ge- C
Mnomic DNA and Western blots with brain extracts were performed.
Routine genotyping was performed by PCR. p
m
sWestern Blotting
4Brains and adrenal glands from E19 and P30 mice of the different
cgenotypes were prepared and analyzed as described (Speidel et
lal., 2003). The following antibodies were used for Western blots:
ipolyclonal rabbit antisera to CAPS1 (Speidel et al., 2003), CAPS2
p(Speidel et al., 2003), Munc18-1 (Synaptic Systems), Secretogranin
(H.H. Gerdes, Heidelberg, Germany), Chromogranin A (WE-14) (Ha-
melink et al., 2002), VMAT1 (Weihe et al., 1994), VMAT2 (Weihe and P
CEiden, 2000), Vo ATPase (Synaptic Systems), and monoclonal anti-
bodies to Synaptotagmin 1 and Syntaxin 1 (Synaptic Systems) and p
sActin (Sigma). For quantification of Western blot signals obtained
in E19 adrenal gland samples, blots were incubated with a HRP- (
ecoupled secondary antibody, and immunoreactive proteins were
visualized with enhanced chemiluminescence (Amersham Biosci- H
mences). Chromogranin A and Actin were used as loading controls.
Signal intensity was determined densitometrically (Agfa-Photo- c
mLook 3.00.07 and TINA 2.0). For the determination of the relative
antibody affinity of anti-CAPS1 and anti-CAPS2 antibodies, exactly E
7homologous sequence stretches including the respective regions
that had been used as antigens (rat CAPS1, aa 218–390; mouse N
wCAPS2, aa 160–333) (Speidel et al., 2003) were expressed as His-
tagged proteins in bacteria, purified on Ni-NTA-beads, and loaded p
−onto SDS-PAGE gels. Coomassie-stained bands were quantified
with the Odyssey imaging system (LI-COR) using bovine serum al- p
fbumin as standard. Defined amounts of fusion proteins (0.4–30 ng)
were then analyzed by Western blots using CAPS1 and CAPS2 an- fisera, respectively. Ratios of signal intensities to loaded protein
ere compared after densitometric analysis.
orphological Methods
resyl violet staining (Sigma) was performed on frozen sections
f E19 and P30 brains and adrenal glands according to standard
rocedures. Images were captured with a Zeiss Axiophot micro-
cope (Zeiss) and a Camedia C-3030 Zoom digital camera (Olym-
us). Immunocytochemistry of adrenal glands was performed as
escribed using affinity-purified polyclonal antibodies to CAPS1
nd CAPS2 (Speidel et al., 2003). Images were captured with an
xiovert 200 LSM510 laser scanning microscope (Zeiss) and ana-
yzed with the LSM510 software. Immunohistochemical analyses
f adrenals with sheep anti-tyrosine hydroxylase (Chemicon), anti-
MAT1, and anti-VMAT2 antibodies, which recognize mouse pro-
eins, were performed as described using Bouin Hollande fixation
Weihe and Eiden, 2000; Weihe et al., 1994). Images were captured
ith an Axiovert 200 LSM510 laser scanning microscope (Zeiss)
nd analyzed with the LSM510 software. Glyoxylic acid staining
as performed according to De la Torre (1980). Ultrastructural
nalyses on adrenals from perfused P30 and E19 mice were per-
ormed according to standard procedures (Augustin et al., 2001)
sing a LEO 912AB transmission electron microscope (Zeiss).
mages were captured with a ProScan CCD camera and analyzed
ith the Analysis version 3.2 software (Soft Imaging System). Iso-
ated chromaffin cells were fixed with 4% paraformaldehyde in PBS
nd incubated with a monoclonal CAPS1 antibody (BD Laborato-
ies) and a polyclonal anti-CAPS2 antibody (Speidel et al., 2003).
ollowing incubation with secondary antibodies (Alexa 488 goat
nti-mouse for CAPS1 and Alexa 555 goat anti-rabbit for CAPS2)
nd several washes, confocal images were taken through the mid-
le of the cell. Images were background subtracted, and a linear
nmixing was performed.
uantitative Analysis of Catecholamines and Catechols
drenals were removed, transferred to 100 l 0.1 M perchloric acid,
nd frozen in liquid nitrogen. Samples were sonicated, and an ali-
uot of 50 l was assayed for protein concentration. After centrifu-
ation at 10,000 g for 10 min, 20 l of the clear supernatant were
njected into an HPLC, coupled with two electrochemical detectors
s previously reported (Fornai et al., 2003), to measure levels of
atecholamines and catechols.
hromaffin Cell Preparation and Infection
ouse embryos at E19 were obtained by caesarean section of
regnant females from timed matings. Adrenal glands were re-
oved, and slices of 80–100 m thickness were prepared as de-
cribed previously (Moser and Neher, 1997). Slices were used for
–6 hr starting shortly after cutting. The preparation of isolated
hromaffin cells followed standard procedures previously pub-
ished (Ashery et al., 2000). For the rescue experiment in Figure 7G,
solated chromaffin cells were infected with 50 l of activated
SFV1-CAPS1-GFP as described (Ashery et al., 1999).
atch-Clamp Analyses and Amperometry
onventional whole-cell recordings were performed with 3–4 M
ipettes and an EPC-9 patch-clamp amplifier together with Pulse
oftware (HEKA). The solutions for adrenal slices were as described
Voets, 2000). For measurements from isolated chromaffin cells, the
xtracellular solution contained 146 mM NaCl, 2.4 mM KCl, 10 mM
EPES, 1.2 mM MgCl2, 2.5 mM CaCl2, 10 mM glucose, and 10
M NaHCO3 (pH 7.4). The intracellular solution for isolated cells
ontained 100 mM Cs-aspartate, 10 mM NaCl, 2 mM Mg-ATP, 0.2
M Na2-GTP, 40 mM Cs-HEPES, 5 mM nitrophenyl-EGTA (NP-
GTA), 4 mM CaCl2, 0.4 mM Furaptra, and 0.4 mM Fura-4F (pH
.2). Capacitance measurements were performed using the Lindau-
eher technique implemented as the “sine + dc” mode of the “soft-
are lock-in” extension of Pulse software. A 1 kHz, 70 mV peak-to-
eak sinusoid stimulus was applied about a DC holding potential of
80 mV. Amperometry recordings on isolated chromaffin cells were
erformed as published (Bruns et al., 2000). The duration of the
oot signal (Figures 4F and 5F and Table S2) was determined as
ollows: the start of the foot signal was defined as the time point
CAPS1 Controls LDCV Loading
87where the current amplitude exceeded two times the standard de-
viation of the average baseline noise. Its end was defined as the
inflection point between the slowly increasing foot signal and the
more rapidly increasing spike current. All experiments were per-
formed at room temperature. Measurements of [Ca2+]i and photoly-
sis of caged Ca2+ was performed as described (Voets, 2000).
TIRFM
TIRFM on wt and homozygous CAPS1 KO chromaffin cells was
performed 8–12 hr after infection with a Neuropeptide Y-Venus
(NPY-Venus) construct. A single-line (488 nm) laser beam was cou-
pled into the epifluorescence port of an Olympus IX70 microscope
equipped with a TIRF condenser (TILL Photonics) and focused off
axis to the most peripheral position on the back focal plane of a
1.45 NA 60× oil immersion objective to generate an evanescent
field with a penetration depth of about 200 nm. Images were col-
lected at 3 Hz with a Micromax 512 BFT CCD camera (Princeton
Instruments) and analyzed using MetaMorph v5.05 (Universal Im-
aging Corporation). The “total number of vesicles per frame” was
counted using the automated object analyzing module of Meta-
Morph, and the secretion events were visually detected as a sud-
den increase in fluorescent intensity followed by a sharp decrease
of fluorescence corresponding to the release of NPY-Venus from
the vesicle. The increase of the fluorescence intensity corres-
ponded to the dequenching of the fluorophore.
Supplemental Data
The Supplemental Data include two supplemental figures and two
supplemental tables and can be found with this article online at
http://www.neuron.org/cgi/content/full/46/1/75/DC1/.
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